Henry S Kingdon

Title: Innovations of Henry S Kingdon

Introduction

Henry S Kingdon is a notable inventor based in Pasadena, California. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions that address critical medical needs. With a total of two patents to his name, Kingdon's work has had a meaningful impact on healthcare.

Latest Patents

Kingdon's latest patents include a pharmaceutical composition and method for the suppression of factor VIII. This composition is designed for administration to human beings and aims to suppress the production of factor VIII inhibitors. Another significant patent is for a viral-safe purified human thrombin. This therapeutic-grade thrombin is described as being essentially free of lipid envelope viruses, with a specific activity ranging from about 2200 NIH units per milligram of protein to about 3200 NIH units per milligram of protein. It is also noted for being essentially homogeneous and suitable for commercial-scale production, making it acceptable for human administration.

Career Highlights

Throughout his career, Kingdon has worked with prominent organizations, including Baxter International Inc. and the International Institute of Cellular and Molecular Pathology. His experience in these institutions has allowed him to contribute to advancements in medical technology and pharmaceutical development.

Collaborations

Some of Kingdon's notable coworkers include Michael J Griffith and Joyce E Lawrence. Their collaborative efforts have likely played a role in the success of his inventions and patents.

Conclusion

Henry S Kingdon's contributions to the pharmaceutical industry through his innovative patents demonstrate his commitment to improving healthcare solutions. His work continues to influence the field and showcases the importance of innovation in medicine.